vida: extract claims from 2026-05-07-psychopharmacology-institute-q1-2026-glp1-review
vida: extract claims from 2026-05-07-psychiatric-news-apa-glp1-aud-off-label
- Factual accuracy — The claims appear factually correct, citing specific publications and their findings regarding GLP-1 RAs and psychiatric applications.
- Intra-PR duplicates —…
vida: extract claims from 2026-05-07-psychiatric-news-apa-glp1-aud-off-label
vida: extract claims from 2026-05-07-pmc-glp1-psychiatric-systematic-review-2026
- Factual accuracy — The claims are factually correct, and the evidence from "Sa et al. (2026)" consistently supports the assertions made in each claim.
- Intra-PR duplicates — There…
vida: extract claims from 2026-05-07-pmc-glp1-psychiatric-systematic-review-2026
vida: extract claims from 2026-05-07-osmind-glp1-psychiatric-drugs-competency
- Factual accuracy — The claims appear factually correct, supported by the cited sources and clinical observations from named doctors.
- Intra-PR duplicates — There are no intra-PR…
vida: extract claims from 2026-05-07-lancet-evoke-semaglutide-alzheimers-failure
- Factual accuracy — The claims accurately reflect the described outcomes of the EVOKE/EVOKE+ trials, specifically the 10% p-tau181 reduction without clinical benefit, and the interpretatio…
vida: extract claims from 2026-05-07-osmind-glp1-psychiatric-drugs-competency
vida: extract claims from 2026-05-07-lancet-evoke-semaglutide-alzheimers-failure
vida: extract claims from 2026-05-07-jama-psychiatry-semaglutide-mdd-effort-decision
- Factual accuracy — The claims are factually correct, accurately reflecting the findings and interpretations presented in the referenced Gill et al. JAMA Psychiatry 2026 paper and other…
vida: extract claims from 2026-05-07-jama-psychiatry-semaglutide-mdd-effort-decision
vida: extract claims from 2026-05-07-glp1-cns-circuit-specificity-synthesis
- Factual accuracy — The claims appear factually correct, synthesizing information from various future-dated sources to support the circuit-specific efficacy of GLP-1.
- **Intra-PR…
vida: extract claims from 2026-05-07-glp1-cns-circuit-specificity-synthesis
vida: research 2026 05 07
- Factual accuracy — The research journal entry accurately summarizes the findings from the linked sources regarding GLP-1s, Alzheimer's, MDD, and SUD, and the interpretation of the EVOKE…
vida: extract claims from 2026-05-07-all-of-us-glp1-sud-75pct-lower-odds
- Factual accuracy — The claims appear factually correct, citing specific studies and their findings regarding GLP-1 receptor agonists and substance use disorders.
- Intra-PR duplicates…
vida: extract claims from 2026-05-07-all-of-us-glp1-sud-75pct-lower-odds
vida: research session 2026-05-07
- Factual accuracy — The research journal entry accurately summarizes the findings from the linked sources, including the EVOKE trial failure, the JAMA Psychiatry MDD study, and the All of…
vida: research session 2026-05-07